Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9355 |
High Similarity |
NPD7075 |
Discontinued |
0.9231 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9216 |
High Similarity |
NPD4380 |
Phase 2 |
0.9193 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9161 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.9097 |
High Similarity |
NPD6801 |
Discontinued |
0.8896 |
High Similarity |
NPD3818 |
Discontinued |
0.8889 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8797 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8795 |
High Similarity |
NPD6559 |
Discontinued |
0.8742 |
High Similarity |
NPD1549 |
Phase 2 |
0.8735 |
High Similarity |
NPD6797 |
Phase 2 |
0.8701 |
High Similarity |
NPD6799 |
Approved |
0.8688 |
High Similarity |
NPD3882 |
Suspended |
0.8683 |
High Similarity |
NPD7251 |
Discontinued |
0.8675 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8659 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8659 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8659 |
High Similarity |
NPD6166 |
Phase 2 |
0.8654 |
High Similarity |
NPD5403 |
Approved |
0.8631 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8631 |
High Similarity |
NPD7808 |
Phase 3 |
0.8616 |
High Similarity |
NPD1934 |
Approved |
0.8563 |
High Similarity |
NPD7074 |
Phase 3 |
0.8553 |
High Similarity |
NPD7411 |
Suspended |
0.8526 |
High Similarity |
NPD5401 |
Approved |
0.8509 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8509 |
High Similarity |
NPD5402 |
Approved |
0.8509 |
High Similarity |
NPD3817 |
Phase 2 |
0.8503 |
High Similarity |
NPD7054 |
Approved |
0.8491 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8447 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8421 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8408 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8354 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8344 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8228 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8221 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8214 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8158 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8144 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8136 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8052 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8024 |
Intermediate Similarity |
NPD919 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7963 |
Intermediate Similarity |
NPD920 |
Approved |
0.7956 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7925 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7925 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7898 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7849 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7841 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7841 |
Intermediate Similarity |
NPD8312 |
Approved |
0.784 |
Intermediate Similarity |
NPD2533 |
Approved |
0.784 |
Intermediate Similarity |
NPD2532 |
Approved |
0.784 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7812 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7766 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD6780 |
Approved |
0.773 |
Intermediate Similarity |
NPD6776 |
Approved |
0.773 |
Intermediate Similarity |
NPD6779 |
Approved |
0.773 |
Intermediate Similarity |
NPD6778 |
Approved |
0.773 |
Intermediate Similarity |
NPD6782 |
Approved |
0.773 |
Intermediate Similarity |
NPD6777 |
Approved |
0.773 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7709 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD3748 |
Approved |
0.761 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD6651 |
Approved |
0.758 |
Intermediate Similarity |
NPD1613 |
Approved |
0.758 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7545 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD37 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7513 |
Intermediate Similarity |
NPD7697 |
Approved |
0.75 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7474 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD943 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7461 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7461 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7459 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7459 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7459 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7452 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7418 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7409 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7401 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7371 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.734 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7306 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7292 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7292 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7288 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7284 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7246 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7245 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7245 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7229 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7205 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7191 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7182 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.717 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7111 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7101
|
Intermediate Similarity |
NPD4662 |
Approved |